Controlling Polysorbate Degradation
From the “AI Pilot Graveyard” to Enterprise- Grade Impact
Relatively Speaking
Accelerating Cross-Sector Integration in Pharma and Nutraceuticals
Tailored Artificial Intelligence (AI)
EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
.webp)
KNOWLEDGE BANK
-
Articles
Trustworthy AI in Drug Discovery: From Innovation to Regulatory Readiness
Artificial intelligence is entering a new phase in drug discovery After years of enthusiasm for predictive models generative chemistry and automated screening attention is shifting from what AI can generate to whether its outputs can be trusted
Quantum Dot: The Future of Personalized Medicine
Cancer is amongst the most significant health hazards around the globe Individualized chemotherapy offers promise for the forthcoming cancer therapy in clinical practice with each patient receiving tailored medication based on essential biological aspects of a specific tumor One of the most pressing issues is the development of innovative ways for personalized
B2B Pharma Magazines: Sponsored Thought Leadership Strategies for Brand Authority
The pharmaceutical industry has never been short of innovation Every year brings breakthroughs in biologics advanced therapies AIdriven drug discovery manufacturing automation precision medicine and digital health
Global CDMO Expansion: Supporting the Growing Advanced Therapy Pipeline
The European advanced therapy sector has spent the better part of two decades proving a scientific point that engineered cells corrected genes and reprogrammed immune systems can deliver durable clinical benefit That argument is now largely settled The question facing pharmaceutical and biotech leadership is industrial rather than scientific whether these therapies can be manufactured consistentl...
Next-Gen Continuous Biomanufacturing: Redefining Efficiency and Quality Standards
Continuous biomanufacturing represents a paradigm shift in the production of biopharmaceuticals offering unparalleled efficiency flexibility and quality control compared to traditional batch processes
Leveraging Blockchain for Drug Traceability and Security in Europe
The area of interest in the pharmaceutical products in the past couple of years has been in the area of traceability and security Recently there has been an increase in fake drugs as well as advanced supply chain management making it difficult to tell the actual quality of the manufactured drugs
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Quantum Dot: The Future of Personalized Medicine
Chandan Adhikari
Certainly, we are all alike, but we are all unique. And the notion that medication would be used in a way that overlooks those disparities is as absurd as walking to a sneaker store to pick up any old...
-
2
B2B Pharma Magazines: Sponsored Thought Leadership Strategies for Brand Authority
Kate Williamson
Decision-makers in the pharmaceutical industry rarely respond to promotional messaging alone. They look for evidence, expertise, and credible perspectives that help solve complex business and scientif...
-
3
Global CDMO Expansion: Supporting the Growing Advanced Therapy Pipeline
Lakshmi
Europe's advanced therapy pipeline is maturing faster than the manufacturing base built to serve it. This article examines how global CDMO expansion is redrawing capacity, cost and control for cel...
-
4
Next-Gen Continuous Biomanufacturing: Redefining Efficiency and Quality Standards
Kate Williamson
Explore the transformative realm of next-gen continuous biomanufacturing, revolutionizing biopharmaceutical production with efficiency, quality control, and flexibility. Uncover key components, benefi...
-
5
Leveraging Blockchain for Drug Traceability and Security in Europe
Debi Jones
One of the interesting use cases of the blockchain technology is that it offers an efficient and secure means of implementing drug traceability and security in Europe. In improving identification, pre...
press releases Read more...
INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)
INOVIO a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPVrelated diseases cancer and infectious diseases today announced that the US Food and Drug Administration FDA has granted accelerated approval for VOCERYQ doruxapapogene ral...
Helsinn announces UK MHRA approval of AKYNZEO® Oral Suspension
Helsinn Healthcare SA a global pharmaceutical group focused on supporting patients with cancer and chronic diseases today announced that the UK Medicines and Healthcare products Regulatory Agency MHRA has granted approval for the oral suspension formulation of AKYNZEO netupitantpalonosetron for the...
Transcripta Bio Announces Research Collaboration to Advance Discovery of New Treatments for Autism Spectrum Disorder
Transcripta Bio an AIpowered drug discovery company focused on neurological and neuromuscular diseases today announced a knowhow agreement with Mayo Clinic focused on the molecular characterization of autism spectrum disorder ASD The collaboration seeks to combine Mayo Clinics clinical genomics and...
Carterra and Grenova Robotics Integrate Carterra Vega™ with KX2 Collaborative Robot to Create Automated HT-SPR Work Cell
Carterra and Grenova Robotics today announced the integration of Carterra Vega highthroughput surface plasmon resonance HTSPR platform with Grenova Robotics KX collaborative robot to create an automated work cell for drug discovery laboratories The integrated system enables researchers
Events Read more...
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
02 - 04
Nov 2026Cancer R&D 2026
Houston, TX, USA
03 - 05
Nov 202610th Dermatology Drug Development
Boston, Massachusetts at The C...
03 - 04
Nov 2026PDA Aseptic Processing of Biopharma Conference
Sheraton Grand Incheon Hotel,...
04 - 05
Nov 2026Advanced Therapies USA
Hynes Convention Center, Bosto...
05 - 05
Nov 2026PDA Contamination Control Strategy Workshop
Sheraton Grand Incheon Hotel,...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
10 - 11
Nov 2026Extractables & Leachables Europe
Parkhotel Schӧnbrunn, Vienna,...
LATEST NEWS Read more...
Pretzel Therapeutics Receives UK Regulatory Authorization to Advance PX578 Into Clinical Development in Patients for the Treatment of POLG-Mediated Primary Mitochondrial Disorders
Pretzel Therapeutics Inc a clinicalstage biotechnology company advancing a new class of medicines designed to restore mitochondrial function improve cellular energetics and impede disease progression across a range of neurological and rare diseases today announced that the Medicines and Healthcare p...
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
TME Pharma NV Euronext Growth Paris ALTME a biotechcompany with clinical assets for brain cancer and eye diseases is pleased to announce a significant next step in the strategic options for its leading oncology asset NOXA olaptesed pegol
Twist Bioscience Launches MRD Express with Rapid Turnaround Time
Twist Bioscience Corporation a midcap growth and value biotech company today launched Twist MRD Express custom panels manufactured at scale with a rapid turnaround time starting within one day Twist MRD Express custom panels enable cancer researchers to investigate tumorassociated genomic variants
Strand Therapeutics Doses First Patients with STX-003, a Systemic Programmable mRNA Therapy Designed for Tumor-Selective Activation
Strand Therapeutics a clinicalstage biotechnology company pioneering programmable mRNA therapeutics today announced that the first patients have been dosed in ASCENT the Phase clinical trial of STX STX is an intravenously delivered selfreplicating mRNA therapy designed
Idorsia and SPV investors partner to unlock the blockbuster potential of TRYVIO/JERAYGO with a targeted launch in specialists
Idorsia Ltd announced a proposed commercialization partnership between Idorsia and noteholders in Idorsia Investments SARL SPV designed to unlock the substantial global commercial opportunity of TRYVIO JERAYGO aprocitentan the first and only dual endothelin receptor antagonist approved for systemic
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
Roche announced today the global launch of the VENTANA BAP SP test This automated readytouse immunohistochemistry IHC assay provides a reliable highly specific diagnostic tool to help clinicians and pathologists accurately identify mesothelioma and distinguish it from other malignancies including no...
